↓ Skip to main content

Cochrane Database of Systematic Reviews

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

Overview of attention for article published in Cochrane database of systematic reviews, March 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
4 news outlets
policy
1 policy source
twitter
1 X user
patent
6 patents
wikipedia
16 Wikipedia pages

Citations

dimensions_citation
655 Dimensions

Readers on

mendeley
695 Mendeley
Title
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Published in
Cochrane database of systematic reviews, March 2012
DOI 10.1002/14651858.cd001447.pub3
Pubmed ID
Authors

Robert G Miller, J D Mitchell, Dan H Moore

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 695 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Korea, Republic of 2 <1%
Colombia 1 <1%
Australia 1 <1%
United Kingdom 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 688 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 125 18%
Student > Master 95 14%
Student > Ph. D. Student 94 14%
Researcher 64 9%
Student > Doctoral Student 35 5%
Other 94 14%
Unknown 188 27%
Readers by discipline Count As %
Medicine and Dentistry 160 23%
Neuroscience 79 11%
Agricultural and Biological Sciences 77 11%
Biochemistry, Genetics and Molecular Biology 52 7%
Nursing and Health Professions 26 4%
Other 87 13%
Unknown 214 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 44. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 November 2023.
All research outputs
#938,817
of 25,381,783 outputs
Outputs from Cochrane database of systematic reviews
#1,863
of 12,999 outputs
Outputs of similar age
#4,451
of 163,294 outputs
Outputs of similar age from Cochrane database of systematic reviews
#21
of 185 outputs
Altmetric has tracked 25,381,783 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,999 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 163,294 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 185 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.